Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 71

1.

Burden and clinical features of chronic obstructive pulmonary disease (COPD).

Pauwels RA, Rabe KF.

Lancet. 2004 Aug 14-20;364(9434):613-20. Review.

PMID:
15313363
2.

Definition, epidemiology and natural history of COPD.

Viegi G, Pistelli F, Sherrill DL, Maio S, Baldacci S, Carrozzi L.

Eur Respir J. 2007 Nov;30(5):993-1013. Review.

3.

Chronic obstructive pulmonary disease in women: exploring gender differences.

Varkey AB.

Curr Opin Pulm Med. 2004 Mar;10(2):98-103. Review.

PMID:
15021178
4.

Contemporary issues in the care of patients with chronic obstructive pulmonary disease.

Urbano FL, Pascual RM.

J Manag Care Pharm. 2005 Jun;11(5 Suppl A):S2-13; quiz S14-6. Review.

PMID:
15934804
5.

Epidemiology of chronic obstructive pulmonary disease.

Antó JM, Vermeire P, Vestbo J, Sunyer J.

Eur Respir J. 2001 May;17(5):982-94. Review.

6.

Chronic obstructive pulmonary disease: the disease and its burden to society.

Halpin DM, Miravitlles M.

Proc Am Thorac Soc. 2006 Sep;3(7):619-23. Review.

PMID:
16963544
7.

Chronic obstructive pulmonary disease: epidemiology, pathogenesis, disease course, and prognosis.

Doherty DE, Briggs DD Jr.

Clin Cornerstone. 2004;Suppl 2:S5-16. Review.

PMID:
15500179
8.

Exacerbations of chronic obstructive pulmonary disease.

Wedzicha JA, Donaldson GC.

Respir Care. 2003 Dec;48(12):1204-13; discussion 1213-5. Review.

9.

Cough and sputum production as risk factors for poor outcomes in patients with COPD.

Miravitlles M.

Respir Med. 2011 Aug;105(8):1118-28. doi: 10.1016/j.rmed.2011.02.003. Epub 2011 Feb 25. Review.

10.

[GOLD guideline and recommendation for role of spirometry in COPD].

Tojo N.

Rinsho Byori. 2003 Aug;51(8):776-81. Review. Japanese.

PMID:
13677938
11.

An official American Thoracic Society public policy statement: Novel risk factors and the global burden of chronic obstructive pulmonary disease.

Eisner MD, Anthonisen N, Coultas D, Kuenzli N, Perez-Padilla R, Postma D, Romieu I, Silverman EK, Balmes JR; Committee on Nonsmoking COPD, Environmental and Occupational Health Assembly.

Am J Respir Crit Care Med. 2010 Sep 1;182(5):693-718. doi: 10.1164/rccm.200811-1757ST. Review.

PMID:
20802169
12.

Epidemiological aspects and early detection of chronic obstructive airway diseases in the elderly.

Lundbäck B, Gulsvik A, Albers M, Bakke P, Rönmark E, van den Boom G, Brøgger J, Larsson LG, Welle I, van Weel C, Omenaas E.

Eur Respir J Suppl. 2003 May;40:3s-9s. Review.

13.

COPD: epidemiology, prevalence, morbidity and mortality, and disease heterogeneity.

Mannino DM.

Chest. 2002 May;121(5 Suppl):121S-126S. Review.

PMID:
12010839
14.

The epidemiology and economics of chronic obstructive pulmonary disease.

Mannino DM, Braman S.

Proc Am Thorac Soc. 2007 Oct 1;4(7):502-6. Review.

PMID:
17878461
15.

Innovations to achieve excellence in COPD diagnosis and treatment in primary care.

Fromer L, Barnes T, Garvey C, Ortiz G, Saver DF, Yawn B.

Postgrad Med. 2010 Sep;122(5):150-64. doi: 10.3810/pgm.2010.09.2212. Review.

PMID:
20861599
16.
17.

Chronic obstructive pulmonary disease: definition and epidemiology.

Mannino DM.

Respir Care. 2003 Dec;48(12):1185-91; discussion 1191-3. Review.

18.

[Pathomechanisms in chronic obstructive pulmonary disease (COPD)].

Glaab T, Hohlfeld JM, Jörres RA, Krug N, Welte T.

Med Klin (Munich). 2006 Dec 15;101(12):951-6. Review. German.

PMID:
17171318
19.

COPD and the response of the lung to tobacco smoke exposure.

Taylor JD.

Pulm Pharmacol Ther. 2010 Oct;23(5):376-83. doi: 10.1016/j.pupt.2010.04.003. Epub 2010 Apr 9. Review.

PMID:
20382250
20.

Global perspective on tobacco control. Part I. The global state of the tobacco epidemic.

Slama K.

Int J Tuberc Lung Dis. 2008 Jan;12(1):3-7. Review.

PMID:
18173869

Supplemental Content

Support Center